Cagrilintide (AM833) is a long-acting synthetic analog of amylin studied for its activity at amylin and calcitonin receptors. It has been evaluated in clinical research related to metabolic and endocrine signaling pathways involved in appetite regulation, energy balance, and glucose control mechanisms.